🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Lung Adenocarcinoma, Stage I

A Phase I Study of HS-20108 in Participants With Advanced Solid Tumors NCT06936735Phase 11 site📍 Shanghai Hansoh BioMedical R&D Company · Tests: HS-20108 Monotherapy TT-702 in Patients With Advanced Solid Tumours. NCT05272709Phase 1, Phase 23 sites📍 London📍 Manchester📍 Southampton Cancer Research UK · Tests: TT-702, Anti-PD-1 and PD-L1 agent A Study of Armored CAR T Cells in People With Cancer NCT07783477Phase 17 sites📍 Basking Ridge📍 Middletown📍 Montvale Memorial Sloan Kettering Cancer Center · Tests: DLL3-SAVVYZ-IL18 CAR T cell Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites📍 Iowa City📍 Boston📍 Royal Oak Novartis Pharmaceuticals · Tests: 225Ac-ETN029, 111In-ETN029 Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20% NCT03351842Phase 21 site📍 Shanghai Shanghai Pulmonary Hospital, Shanghai, China · Tests: cis Platinum/Carboplatin, Pemetrexed Disodium, Undergo surgery A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab NCT07391670Phase 119 sites📍 Fitzroy📍 St Albans📍 Woolloongabba AstraZeneca · Tests: SC durvalumab + rHu, IV durvalumab, Tremelimumab JMT106 Injection in the Treatment of Advanced Solid Tumors NCT07275073Phase 11 site📍 Zhejiang Shanghai JMT-Bio Inc. · Tests: JMT106 Injection IDOV-Immune for Advanced Solid Tumors NCT06910657Phase 15 sites📍 St Louis📍 Houston📍 San Antonio ViroMissile, Inc. · Tests: IDOV-Immune (oncolytic vaccinia virus) MOv19-BBz CAR T Cells in FRa+ Cancers NCT07116057Phase 11 site📍 Philadelphia University of Pennsylvania · Tests: MOv19-BBz CAR T cells, Cyclophosphamide/Fludarabine, FRa Expression Testing Adjuvant Benmelstobart for Stage IB, Grade 3 Invasive Lung Adenocarcinoma NCT06528847Phase 21 site📍 Shanghai Shanghai Pulmonary Hospital, Shanghai, China · Tests: Benmelstobart Osimertinib to Suppress the Progression of Remaining GGN for EGFR Mutation-positive Stage IB-IIIA Lung Adenocarcinoma NCT05528458Phase 21 site📍 Seoul Samsung Medical Center · Tests: Osimertinib 80Mg Tab Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma NCT07235280EARLY Phase 11 site📍 Los Angeles Jonsson Comprehensive Cancer Center · Tests: Biospecimen Collection, Computed Tomography Assisted Biopsy, Dapagliflozin Propanediol, Questionnaire Administration A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988Phase 1, Phase 214 sites📍 Los Angeles📍 Newport Beach📍 Aurora Volastra Therapeutics, Inc. · Tests: VLS-1488 Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors NCT05797168Phase 1, Phase 260 sites📍 Duarte📍 Irvine📍 La Jolla AstraZeneca · Tests: Torvutatug samrotecan, Saruparib, Bevacizumab, Carboplatin, Palacaparib A Study of MT-4561 in Patients With Various Advanced Solid Tumors NCT06943521Phase 1, Phase 26 sites📍 Los Angeles📍 Grand Rapids📍 Columbus Tanabe Pharma America, Inc. · Tests: MT-4561 Study of BPI-572270 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT07435038Phase 1, Phase 27 sites📍 Blacktown📍 Randwick📍 Sydney Betta Pharmaceuticals Co., Ltd. · Tests: BPI-572270 A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors NCT06307925Phase 11 site📍 Guangzhou HC Biopharma Inc. · Tests: HC010 Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) NCT05579366Phase 1, Phase 266 sites📍 Phoenix📍 Tucson📍 Los Angeles Genmab · Tests: Rina-S, Carboplatin, Bevacizumab, Pembrolizumab, Erythromycin A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing NCT06066138Phase 11 site📍 Bethesda National Cancer Institute (NCI) · Tests: Atezolizumab A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations NCT07610798Phase 1, Phase 21 site📍 Guangzhou Shenzhen Ionova Life Sciences Co., Ltd. · Tests: INV-8989 Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors NCT06596915Phase 11 site📍 Beijing Shandong Boan Biotechnology Co., Ltd · Tests: BA1302 MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors NCT05076760Phase 12 sites📍 Tampa📍 Durham Memgen, Inc. · Tests: MEM-288 Intratumoral Injection, Nivolumab, Docetaxel TCR1188-ABC Cells in KRAS-mutated Cancers NCT07594067Phase 11 site📍 Philadelphia University of Pennsylvania · Tests: TCR1188-ABC cells, Fludarabine + Cyclophosphamide combination, Tocilizumab FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC NCT06303505Phase 1, Phase 229 sites📍 Birmingham📍 New Haven📍 Atlanta Gilead Sciences · Tests: TUB-040 A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors NCT07169734Phase 1, Phase 241 sites📍 Phoenix📍 Los Angeles📍 New Haven Alentis Therapeutics AG · Tests: ALE.P03, ALE.P03, ALE.P03 Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers NCT06562192Phase 129 sites📍 Birmingham📍 Los Angeles📍 Palo Alto Novartis Pharmaceuticals · Tests: [68Ga]Ga-NNS309, [177Lu]Lu-NNS309 Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma. NCT06440057Phase 1, Phase 21 site📍 Beijing Suzhou Zelgen Biopharmaceuticals Co.,Ltd · Tests: ZG006 Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496Phase 1, Phase 23 sites📍 Gilbert📍 Tucson📍 Seattle University of Arizona · Tests: Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS NCT06895031Phase 21 site📍 Beijing Guangzhou JOYO Pharma Co., Ltd · Tests: JYP0015 A Clinical Study to Evaluate the Safety and Tolerability of AWT020 in Patients With Advanced Malignancies NCT06839105Phase 113 sites📍 Fuzhou📍 Guangzhou📍 Harbin Shanghai Junshi Bioscience Co., Ltd. · Tests: Taxol, Cisplatin or Carboplatin, Pemetrexed, Oxaliplatin, Capecitabine
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy